The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 2265-2270
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinreich, M. A.
Right arrow Articles by Hogquist, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinreich, M. A.
Right arrow Articles by Hogquist, K. A.

Thymic Emigration: When and How T Cells Leave Home1

Michael A. Weinreich and Kristin A. Hogquist2

Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN 55455

The thymus supports the differentiation of multiple distinct T cell subsets that play unique roles in the immune system. CD4 and CD8 {alpha}/β T cells, {gamma}/{delta} T cells, NKT cells, regulatory T cells, and intraepithelial lymphocytes all develop in the thymus and must leave it to provide their functions elsewhere in the body. This article will review recent research indicating differences in the time and migration patterns of T cell subsets found in the thymus. Additionally, we review current understanding of the molecules involved in thymocyte emigration, including the sphingolipid receptor S1P1 and its regulation by the Krüppel-like transcription factor KLF2.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants R01 AI 39560 (to K.A.H.) and T32 AI007313 (to M.A.W.).

2 Address correspondence and reprint requests to Dr. Kristin A. Hogquist, 6-108 Nils Hasselmo Hall, 312 Church Street Southeast, Minneapolis, MN 55455. E-mail address: hogqu001{at}umn.edu

3 Abbreviations used in this paper: Treg, regulatory T cell; DP, double positive; HSA, heat-stable Ag; IEL, intraepithelial lymphocyte; KLF2, Krüppel-like factor 2; KO, knockout; mEC, medullary epithelial cell; S1P, sphingosine 1-phosphate; SP, single positive; TSA, tissue-specific Ag.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Matsushita, S. Ohya, Y. Suzuki, H. Itoda, T. Kimura, H. Yamamura, and Y. Imaizumi
Inhibition of Kv1.3 potassium current by phosphoinositides and stromal-derived factor-1{alpha} in Jurkat T cells
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1079 - C1085.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Shakib, G. E. Desanti, W. E. Jenkinson, S. M. Parnell, E. J. Jenkinson, and G. Anderson
Checkpoints in the Development of Thymic Cortical Epithelial Cells
J. Immunol., January 1, 2009; 182(1): 130 - 137.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. J. Gonzalez-Cabrera, E. Jo, M. G. Sanna, S. Brown, N. Leaf, D. Marsolais, M.-T. Schaeffer, J. Chapman, M. Cameron, M. Guerrero, et al.
Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup Interactions
Mol. Pharmacol., November 1, 2008; 74(5): 1308 - 1318.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.